Updated Jul 16, 2026
STERTZER SIMON H has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $952K. Historical track record: 5/5 stars across 3 tracked purchases.
Simon H. Stertzer is a director at BioCardia, Inc., a clinical-stage company focused on developing therapies for cardiovascular and pulmonary diseases. He has been involved in the company through various SEC filings, indicating his role in corporate governance.
| Role | Director |
|---|---|
| Notability | 20/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★★★★ (5/5) |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 10000% |
| 90-day win rate | 6667% |
| Avg 5-day return | +2184.20% |
| Avg 30-day return | +1501.99% |
| Avg 90-day return | +188.65% |
| Best 30-day return | +2672.41% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-24 | BCDA | BioCardia, Inc. | P — Open-market purchase | 39.0K | $1.00 | $39K |
| 2026-06-24 | BCDA | BioCardia, Inc. | P — Open-market purchase | 70.2K | $0.92 | $65K |
| 2025-09-19 | BCDA | BioCardia, Inc. | P — Open-market purchase | 398.4K | $1.25 | $498K |
| 2025-06-30 | BCDA | BioCardia, Inc. | P — Open-market purchase | 72.3K | $2.08 | $150K |
| 2025-04-23 | BCDA | BioCardia, Inc. | P — Open-market purchase | 105.0K | $1.91 | $200K |
Simon H. Stertzer is a director at BioCardia, Inc., a clinical-stage company focused on developing therapies for cardiovascular and pulmonary diseases. He has been involved in the company through various SEC filings, indicating his role in corporate governance.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 8 open-market purchases ($952K) and 0 open-market sales () across all tracked filings.
Across 3 tracked purchases, STERTZER SIMON H averaged +1502.0% avg 30-day return with a 10000% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live STERTZER SIMON H profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.